Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein STAAU_R4

Details for Australian Patent Application No. 2002224692 (hide)

Owner Targanta Therapeutics Inc.

Inventors Dubow, Michael; Pelletier, Jerry; Gros, Philippe

Agent Spruson & Ferguson

Pub. Number AU-B-2002224692

PCT Pub. Number WO02/50106

Priority 60/256,489 20.12.00 US

Filing date 19 December 2001

Wipo publication date 1 July 2002

Acceptance publication date 24 May 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/005 (2006.01) Peptides having more than 20 amino acids - from viruses

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

24 March 2005 Change of Name(s) of Applicant(s), Section 104

  Phagetech, Inc. The name of the applicant has been changed to Targanta Therapeutics Inc. 2004

24 May 2007 Application Accepted

  Published as AU-B-2002224692

20 September 2007 Standard Patent Sealed

17 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002224693-THERMALLY CONVERTIBLE LITHOGRAPHIC PRINTING PRECURSOR

2002224691-NETWORK BASED SYSTEM FOR REAL-TIME TRADING OF PHYSICAL COMMODITIES